RxDoctor Payments Data

Daniel Spencer, DPM

Podiatrist · Traverse City, MINPI 1265924724

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (55.0%), travel and lodging and education — rather than concentrated in one kind of arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 18.6%. Reporting peaked in 2023 at $2,016 and has fallen 83.6% since, to $330 in 2025.

$6,925in general payments, 2019–2025

Across 83 payments — averaging $83.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paragon 28, Inc.$1K
  • Medwest Associates$1K
  • Stryker$654
  • Pylant Medical$581
  • Integra Lifesciences Corporation$508
  • Medical Device Business Services, Inc.$470
  • plus $2K from 15 others

What the payments were for

  • Travel & lodging$2,02729%
  • Food & beverage$3,80855%
  • Education$1,09116%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,925 in reported general payments places this provider in the 85th percentile of 302 podiatrist providers in Michigan.

See all podiatrist providers in Michigan

Medicare billing

Part B allowed, 2024
$86,898
Medicare patients
259
Services billed
1,090

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox50$1,122
Ammonium Lactate25$457
Clotrimazole14$262
Terbinafine Hcl12$142
Doxycycline Hyclate13$76
Gabapentin11$50

Paid to pharmacies, not to this prescriber.

Other podiatrist in Traverse City

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →